Cogent Biosciences Inc (COGT) returns
Cogent Biosciences returns over 5 years
$1,000 invested in Cogent Biosciences five years ago was worth $3,658 at the close on October 30, 2026, with dividends reinvested: an average return of 29.6% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -3.1% | — | $968.77 | -0.9% |
| 3 months | -25.0% | — | $750.00 | +2.1% |
| Year to date | -12.7% | — | $873.31 | +11.7% |
| 1 year | +91.4% | — | $1,914 | +12.4% |
| 3 years | +275.5% | +55.4% | $3,755 | +88.5% |
| 5 years | +265.8% | +29.6% | $3,658 | +76.0% |
Cogent Biosciences return by calendar year
| Year | COGT | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -12.7% | +11.7% | -24.4% |
| 2025 | +355.4% | +17.7% | +337.7% |
| 2024 | +32.7% | +24.9% | +7.8% |
| 2023 | -49.1% | +26.2% | -75.3% |
| 2022 | +34.7% | -18.2% | +52.9% |
| 2021 | -23.6% | +28.7% | -52.3% |
| 2020 | +289.9% | +18.4% | +271.6% |
| 2019 | -83.6% | +31.2% | -114.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: COGT financials
No forecast, no recommendation. This page describes Cogent Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.